|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 550.30 INR | -0.31% |
|
+5.83% | -18.93% |
| Capitalization | 2.65TCr 29Cr 25Cr 24Cr 22Cr 41Cr 44Cr 276.88Cr 107.22Cr 1.25TCr 110.35Cr 107.99Cr 4.59TCr | P/E ratio 2026 * |
16.9x | P/E ratio 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise value | 2.65TCr 29Cr 25Cr 24Cr 22Cr 41Cr 44Cr 276.88Cr 107.22Cr 1.25TCr 110.35Cr 107.99Cr 4.59TCr | EV / Sales 2026 * |
1.58x | EV / Sales 2027 * | 1.48x |
| Free-Float |
62.24% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Solara Active Pharma Sciences Limited
More press releases
| 1 day | -0.31% | ||
| 1 week | +5.83% | ||
| Current month | +7.01% | ||
| 1 month | -2.61% | ||
| 3 months | -19.02% | ||
| 6 months | +15.90% | ||
| Current year | -18.93% |
| 1 week | 524.55 |  | 580 |
| 1 month | 509.4 | | 595.85 |
| Current year | 442.8 | | 734.4 |
| 1 year | 442.8 | | 784.4 |
| 3 years | 286 | | 882.8 |
| 5 years | 286 | | 1,859.95 |
| 10 years | 134.5 | | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | 53 | 01/01/2024 | |
| General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 11/04/2018 | |
| Director/Board Member | 57 | 11/04/2018 | |
Arun Pillai
BRD | Director/Board Member | 64 | 04/08/2021 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.31% | +5.83% | -30.07% | +24.42% | 30Cr | |
| -1.26% | -5.70% | +20.67% | +168.32% | 90TCr | |
| -0.15% | -1.81% | +35.03% | +13.78% | 49TCr | |
| -1.31% | -0.88% | +26.64% | +34.42% | 40TCr | |
| +2.19% | +2.82% | +23.62% | +4.87% | 33TCr | |
| -0.10% | -1.86% | +27.45% | +19.99% | 28TCr | |
| -0.41% | +2.28% | +18.74% | +25.02% | 26TCr | |
| -0.79% | -2.85% | -4.04% | -10.75% | 25TCr | |
| -3.42% | -4.91% | -61.94% | -33.36% | 21TCr | |
| -2.63% | -4.82% | +17.85% | +12.49% | 18TCr | |
| Average | -0.84% | -0.93% | +7.39% | +25.92% | 32.97TCr | |
| Weighted average by Cap. | -0.80% | -2.41% | +16.86% | +54.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68TCr 19Cr 16Cr 15Cr 14Cr 26Cr 28Cr 175.53Cr 68Cr 793.44Cr 70Cr 68Cr 2.91TCr | 1.79TCr 20Cr 17Cr 16Cr 15Cr 28Cr 30Cr 187.44Cr 73Cr 847.26Cr 75Cr 73Cr 3.1TCr |
| Net income | 160Cr 1.77Cr 1.53Cr 1.43Cr 1.33Cr 2.46Cr 2.68Cr 17Cr 6.47Cr 76Cr 6.66Cr 6.52Cr 276.77Cr | 150Cr 1.66Cr 1.43Cr 1.34Cr 1.25Cr 2.3Cr 2.51Cr 16Cr 6.07Cr 71Cr 6.24Cr 6.11Cr 259.47Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,775
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 550.30 ₹ | -0.31% | 94,731 |
| 05/25/05 | 552.00 ₹ | +0.35% | 59,424 |
| 04/25/04 | 550.05 ₹ | -1.36% | 1,61,796 |
| 03/25/03 | 557.65 ₹ | +6.47% | 15,40,744 |
| 02/25/02 | 523.75 ₹ | +0.72% | 66,486 |
Delayed Quote NSE India S.E., December 08, 2025 at 05:19 pm IST
More quotes
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
550.30INR
Average target price
566.00INR
Spread / Average Target
+2.85%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition